Tissue antigen distribution in hepatocellular carcinoma

Area of Science:

• Hepatology
• Oncology
• Virology

Background:

• Hepatocellular carcinoma (HCC) is a significant global health concern.
• Identifying reliable biomarkers for HCC diagnosis and understanding its etiology are crucial.
• Alpha 1-antitrypsin (AAT), alpha-fetoprotein (AFP), and hepatitis B virus (HBV) are implicated in liver disease.

Purpose of the Study:

• To investigate the expression of AAT, AFP, and HBV antigens in HCC.
• To compare the specificity of AAT and AFP as markers in HCC versus cirrhosis.
• To explore the association between HBV infection and HCC.

Main Methods:

• Immunohistochemical analysis was performed on 63 HCC samples.
• AAT and AFP expression was also assessed in 54 non-HCC cirrhotic liver samples.
• Detection of hepatitis B surface antigen (HBsAg) was conducted.

Main Results:

• AAT was expressed in 82.5% of HCC and 53.7% of cirrhosis cases.
• AFP was detected in 41.2% of HCC but not in any cirrhosis controls.
• HBsAg positivity was observed in 31.7% of HCC cases.

Conclusions:

• AFP demonstrates higher specificity as a biomarker for malignant cellular transformation in HCC compared to AAT.
• The frequent presence of HBsAg in HCC supports a strong link between HBV infection and liver cancer development.
• These findings aid in understanding HCC pathogenesis and biomarker utility.